Skip to main content
Equibles

Caption Management, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1706766 OKLAHOMA CITY, OK
Back to TEVA Full portfolio

Position in TEVA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,752,254
+$316,908 QoQ
Shares Held
258,331
-7.8% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#159
of 675 holders
Holding Since
Dec 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Derivatives in TEVA

reported options exposure · as of Jun 30, 2026
CallValue
$43,349,460
CallShares
1,279,500
PutValue
$22,852,060
PutShares
674,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Caption Management, LLC holds $32,819,609 across 14 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (26.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TEVA
Teva Pharmaceutical Industries Ltd
This page 		258,331 $8,752,254
2 UTHR
UNITED THERAPEUTICS Corp
 9,333 $5,056,899
3 NBIX
Neurocrine Biosciences Inc
 29,500 $4,971,930
4 ANIP
Ani Pharmaceuticals Inc
 40,000 $3,311,200
5 PRGO
PERRIGO Co plc
 253,459 $2,633,439
6 KNSA
Kiniksa Pharmaceuticals International, plc
 25,000 $1,598,750
7 XERS
Xeris Biopharma Holdings, Inc.
 197,863 $1,567,074
8 EOLS
Evolus, Inc.
 216,316 $1,501,233

All Filings in TEVA

Export CSV
45 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,752,254 258,331
2026-06-30 $43,349,460 1,279,500
2026-06-30 $22,852,060 674,500
2026-03-31 $32,815,740 1,089,500
2026-03-31 $20,315,940 674,500
2026-03-31 $8,435,346 280,058
2025-12-31 $5,290,095 169,500
2025-12-31 $2,028,650 65,000
2025-09-30 $1,616,000 80,000
2025-03-31 $10,179,551 662,300
2025-03-31 $5,583,921 363,300
2025-03-31 $3,993,126 259,800
2024-12-31 $1,016,837 46,136
2024-12-31 $12,016,208 545,200
2024-12-31 $11,130,200 505,000
2024-09-30 $9,911,000 550,000
2024-09-30 $3,153,500 175,000
2024-09-30 $3,321,086 184,300
2024-06-30 $692,250 42,600
2024-06-30 $10,156,250 625,000
2024-03-31 $1,181,007 83,700
2023-09-30 $283,560 27,800
2023-09-30 $3,768,502 369,461
2023-09-30 $4,107,540 402,700
2023-06-30 $2,967,573 394,100
2023-06-30 $2,680,604 355,990
2022-12-31 $18,021,120 1,976,000
2022-12-31 $21,515,904 2,359,200
2022-12-31 $3,739,200 410,000
2022-09-30 $7,118,668 882,115
2022-09-30 $13,597,950 1,685,000
2022-09-30 $15,946,320 1,976,000
2022-06-30 $14,859,520 1,976,000
2022-06-30 $6,245,269 830,488
2022-06-30 $12,671,200 1,685,000
2022-03-31 $18,554,640 1,976,000
2022-03-31 $5,511,817 586,988
2022-03-31 $15,822,150 1,685,000
2021-12-31 $13,496,850 1,685,000
2021-12-31 $15,827,760 1,976,000
2021-12-31 $6,408,000 800,000
2021-06-30 $495,000 50,000
2021-03-31 $69,240 6,000
2021-03-31 $577,000 50,000
2020-12-31 $482,500 50,000